Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2007

View Archived Issues

Novel series of anticancer compounds disclosed in recent patents

Recent Inotek patent reports new agents for treating urinary incontinence

Novel diagnostic agents imparted in recent patents

Cytyc completes acquisition of Adeza Biomedical

Genta files appeal against FDA decision on Genasense for CLL

Lilly completes acquisition of Hypnion

Survival benefit for lenalidomide plus low-dose dexamethasone in multiple myeloma

Immune Response changing name to Orchestra Therapeutics

MM-093 begins pilot study in autoimmune uveitis

Amgen updates Vectibix progress

IND clearance for phase II study of CollaRx Bupivacaine Implant in hysterectomy

Vekacia demonstrates efficacy in vernal keratoconjunctivitis phase III trial

Erbitux and platinum-based chemotherapy increases survival in SCCHN

PRT-054021 effective and safe for VTE prevention after knee replacement surgery

Tovaxin reduces annualized relapse rate in MS

Zentase meets endpoints in phase III exocrine pancreatic insufficiency trials

Positive findings for guanilib in animal models of experimental colitis

New Nav1.8 channel blockers with potential utility in chronic pain management

Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma

NP-1 begins two phase IIb trials for neuropathic pain

Phase II trial studies glufosfamide for soft tissue sarcoma

Alteon and Oxis expand licensing deal

Phase IIa Alzheimer's study of MEM-1003 completes enrollment

Phase II study of Curaxin CBLC-102 in prostate cancer advances to next stage

Novel PARP-1 inhibitor described by Abbott

NDA filing for local dental anesthetic reversal agent NV-101

HepaGam B approved to prevent hepatitis B recurrence in liver transplant patients

Intrinsa launched in U.K.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...